80 percent skin grafts NON burns

With 2 announcements today interesting that people choose to comment on the anti ageing applications which whilst exciting best case is still years away rather than the expanding sales that are right in front of us with the second announcement.

Regarding RECELL use for soft tissue reconstruction:
80 percent of wounds requiring skin grafting are not burns; and
we have data RECELL already works for non burn wounds by majorly reducing need for grafting and donor wounds; and
this will be shown in 2022 with top line data in the soft-tissue reconstruction trial; and
FDA approval will likely follow without too much fuss given the comprehensive safety data already accumulated on the RECELL device and demonstrated benefit; and
valid reimbursement code already in place that already covers soft tissue reconcstruction meaning sales will commence from FDA approval

This all = sales for RECELL will expand significantly in the coming 2-5 years as it becomes more and more popular option for reducing skin grafting for all kinds of soft tissue reconstruction.

After discussions with surgeons about this product and with the mounting evidence of reductions of grafting in all wounds that within 5 years this will be widely used standard of care for wounds requiring grafting. It is too good to not adopt - unethical even given the wounds created from grafting are tremendously painful and horrible in their own right so reducing them is a substantial patient benefit too good to ignore.

IMO this will predictably happen in the US and then the world will follow. I believe annual sales of RECELL within 5 years will surpass the current market cap (400 million).